| Term 
 | Definition 
 
        | CH 8 Cholinoceptor-Blocking Drugs Antimuscarinic   
| Unknown mechanism in CNS; reduces vertigo | Tachycardia, blurred vision, xerostomia, delirium | Prevention of motion sickness and postoperative nausea and vomiting |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |  CH 8 Cholinoceptor-Blocking Drugs Antimuscarinic   
| Competitive antagonism at all M receptors; causes mydriasis and cyclopegia (paralysis of ciliary muscle), long duration (5-6 days) | Increased intraocular pressure in glaucoma | Retinal examination; prevention of synechiae (adhesion of iris to cornea or lens) after surgery |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 8 Cholinoceptor-Blocking Drugs Antimuscarinic   
| Like atropine but shorter duration of action (15-60 min) | Blurred vision | Retinal examination |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 8 Cholinoceptor-Blocking Drugs Antimuscarinic   
| Competitive, nonselective antagonist at M receptors, inhibits bronchoconstriction by Vagus n. | Xerostemia, cough | Prevention and relief of acute bronchospasm; COPD bronchodilator |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 8 Cholinoceptor-Blocking Drugs Antimuscarinic    
| Nonselective muscarinic antagonist, reduces detrusor smooth muscle tone  | Tachycardia, constipation, increased intraocular pressure, xerostemia | Relieve bladder spasm after urologic surgery (prostatectomy); urge incontinence |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 8 Cholinoceptor-Blocking Drugs Antinicotinic - Ganglion Blocker    
| Nondepolarizing competitive N receptor antagonist; crosses blood-brain barrier and enters CNS | Sedation, tremor, choreiform movements, mental aberrations | Formerly used for hypertension, now sometimes used for smoking cessation |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 8 Cholinoceptor-Blocking Drugs Cholinesterase Regenerator   
| High affinity for phosphorous atom but does not enter CNS; binds to organophosphate-inactivated acetylcholinesterase and removes organophosphate | Muscle weakness in overdose | Antidote for early stage cholinesterase inhibitor poisoning |    |  | 
        |  |